etryptamine
Sign in to saveAlso known as α-ethyltryptamine, αET, alpha-ethyltryptamine, 3-(2-aminobutyl)indole
α-Ethyltryptamine (αET, AET), also known as etryptamine, is an entactogen and stimulant drug of the tryptamine family. It was originally developed and marketed as an antidepressant under the brand name Monase by Upjohn in the 1960s before being withdrawn due to toxicity.
Key facts
- Drug.verifiedrevid
- 447115140
- Drug.drug_name
- α-Ethyltryptamine
- Drug.INN
- Etryptamine
- Drug.USAN
- Etryptamine
- Drug.image
- AET.svg
- Drug.image_class
- skin-invert-image
- Drug.width
- 200px
- Drug.image2
- Alpha-Ethyltryptamine-3d-sticks.png
- Drug.image_class2
- bg-transparent
- Drug.width2
- 235px
- Drug.tradename
- Monase
- Drug.routes_of_administration
- Oral
- Drug.class
- Entactogen; Stimulant; Monoamine releasing agent; Serotonin receptor agonist; Monoamine oxidase inhibitor
- Drug.legal_BR
- F2
- Drug.legal_CA
- Schedule III
- Drug.legal_US
- Schedule I
- Drug.legal_UK
- Class A
- Drug.legal_DE
- Anlage I
via Wikipedia infobox
Wikidata facts
- Mass
- 188.131349
Show 4 more facts
- chemical formula
- C₁₂H₁₆N₂
- World Health Organisation international non-proprietary name
- etryptamine
- canonical SMILES
- CCC(CC1=CNC2=CC=CC=C21)N
- Commons category
- Alpha-Ethyltryptamine
Sources (2)
via Wikidata · CC0
~12 min read
Article
22 sectionsContents
- Use and effects
- Side effects
- Overdose
- Interactions
- Pharmacology
- Pharmacodynamics
- Pharmacokinetics
- Chemistry
- Synthesis
- Analogues
- History
- Society and culture
- Names
- Recreational use
- Legal status
- Canada
- United Kingdom
- United States
- Research
- See also
- References
- External links
α-Ethyltryptamine (αET, AET), also known as etryptamine, is an entactogen and stimulant drug of the tryptamine family. It was originally developed and marketed as an antidepressant under the brand name Monase by Upjohn in the 1960s before being withdrawn due to toxicity.
Side effects of αET include facial flushing, headache, gastrointestinal distress, insomnia, irritability, appetite loss, and sedation, among others. A rare side effect of αET is agranulocytosis. αET acts as a releasing agent of serotonin, norepinephrine, and dopamine, as a weak serotonin receptor agonist, and as a weak monoamine oxidase inhibitor. It may also produce serotonergic neurotoxicity. αET is a substituted tryptamine and is closely related to α-methyltryptamine (αMT) and other α-alkylated tryptamines.